Clinical Trial 56084

Skokie, IL 60077


Summary:

Phase 3 study involving GLP agonist like Ozempic plus second agent vs Monjuaro as add on therapy to metformin plus or minus jardiance or farxiga in patients with type 2 diabetes who are not adequately controlled on current therapy.  The study will last 76 weeks.   



Criteria:

Have Type 2 Diabetes 

Hemoglobin  A1c greater than 7.0 

BMI greater than 27

On Metformin plus or minus Jardaince or Farxiga 


Qualified Participants May Receive:

Compensation for time 


Available At:

Evanston Premier Healthcare Research
10024 Skokie Boulevard
Skokie, IL 60077
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 25 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.